Liver cancer breakthrough? study tests surgery vs. drug maintenance after successful initial therapy
NCT ID NCT07410715
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 100 liver cancer patients whose tumors shrank or disappeared after initial therapy. It compares two follow-up options: surgery to remove any remaining cancer, or continuing medication (maintenance therapy). The goal is to see which approach better prevents the cancer from coming back and helps patients live longer. Researchers will track outcomes like recurrence and survival over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PD-1/PD-L1 inhibitor ± tyrosine kinase inhibitor (TKI)
What this could lead to
If successful, this study could show whether surgery or continued medication is better for liver cancer patients who improved after initial therapy, guiding future treatment decisions.
What could go wrong
This is a non-randomized study with only 100 participants, so results may not apply to all patients. The best approach may depend on individual factors not fully captured here.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••